Welcome to the e-CCO Library!

P122: Longitudinal follow-up of body mass index as a predictor for severe disease course in children with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Yerushalmy-Feler*1,2, S. Cohen1,2

Created: Friday, 22 February 2019, 9:41 AM
P122: Low Risk of new dysplastic lesions during inflammatory bowel disease surveillance with dye-cromoendoscopy: a multicenter population-based retrospective study
Year: 2022
Source: ECCO'22
Authors: Saiz Chumillas, R.M.(1);Alba, L.(1);Gonzalez-Lama, Y.(2);Velayos, B.(3);Suarez, P.(4);Maroto-Martin, C.(5);Nuñez, A.(6);Hernandez, L.(7);Relea, L.(2);Fernandez-Salazar, L.(3);Sierra-Ausin, M.(4);Barrio, J.(5);Muñoz, F.(6);Arias, L.(1);Sicilia, B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P122: Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
Year: 2021
Source: ECCO'21 Virtual
Authors: Levartovsky, A.(1);Barash, Y.(2,3);Ben-Horin, S.(1);Ungar, B.(1);Klang, E.(2,3);Soffer, S.(3);Amitai, M.M.(2);Kopylov, U.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P122: Magnetic resonance index of activity (MaRIA) and Clermont score are two MRI indices which are highly and equally effective in detecting mucosal healing in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buisson A.*1,2, Pereira B.3, Goutte M.1,2, Reymond M.1, Allimant C.1, Bommelaer G.1,2, Hordonneau C.4

Created: Wednesday, 20 February 2019, 10:36 AM
P122: Role of diffusion-weighted imaging in MRI-enterography for the evaluation of surgical risk in patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Testa*1, A. Rispo1, P. Mainenti2, D. Musto1, N. Imperatore1, M. Rea1, O.M. Nardone1, M. L. Taranto1, F. Castiglione1

Created: Friday, 22 February 2019, 9:49 AM
P122: Vitamin D activates human intestinal fibroblasts
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Gisbert-Ferrándiz1*, P. Salvador1, D.C. Macias-Ceja2, J. Cosín-Roger2, D. Ortiz-Masiá3,4, F. Navarro-Vicente5, S. Calatayud1,4, C. Hernández2, M.D. Barrachina1,4

Created: Thursday, 21 February 2019, 9:14 AM
P123 Sarcopenia is a predictor for severe disease course in paediatric inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Atlan1,2, L.T. Pratt1,2, S. Cohen2,3, S. Shiran1,2, A. Yerushalmy-feler2,3

Created: Thursday, 30 January 2020, 10:12 AM
P123: Characteristics of small bowel involvement and association with clinical outcome in patients with Crohn's disease
Year: 2022
Source: ECCO'22
Authors: Yoon, H.(1);Park, J.(1);Kim, H.Y.(2);Lee, Y.J.(2);Shin, C.M.(1);Park, Y.S.(1);Kim, N.(1);Lee, D.H.(1);
Created: Friday, 11 February 2022, 3:52 PM
P123: Development of an end-to-end Mayo endoscopic score machine learning algorithm for use in clinical trials of ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vieira, M.(1)*;Mishkin, D.S.(2);Gaither, K.W.(3);Safran, M.(4);Dashuta, A.(4);Tarakanov, A.(4);Zfira, L.(4);Fuerst, T.(5);
Created: Friday, 14 July 2023, 10:48 AM
P123: MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buisson A.*1,2, Hordonneau C.3, Goutorbe F.1,4, Allimant C.1, Goutte M.1,2, Reymond M.1, Pereira B.5, Bommelaer G.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P123: Significance of serological markers in the disease course of ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Kovacs*1, N. Sipeki1, K. Palatka1, I. Altorjay1, K. Fechner2, 
G. L. Norman3, Z. Shums3, G. Veres4, P. L. Lakatos5, M. Papp1

Created: Friday, 22 February 2019, 9:49 AM
P123: The effect of necrosis inhibition on acute DSS colitis model of inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Lee1,2*, J.S. Koo2, C.H. Kim1, S.H. Hwang1, J.W. Choe2, S.Y. Kim2, S.W. Jung2, H.J. Yim2, Y.T. Jeen2, S.W. Lee2

Created: Thursday, 21 February 2019, 9:14 AM
P123: The fully-automated LIAISON Calprotectin immunoassay from DiaSorin can distinguish between IBD and IBS patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Vicente Steijn*1, J. M. Jansen2, R. Bisheshar1, M. Romeijn1, I-A. Haagen1

Created: Friday, 22 February 2019, 9:41 AM
P123: Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn's disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Bourgonje, A.R.(1);Alexdottir, M.(2);Loveikyte, R.(1);Bay-Jensen, A.C.(2);van Dullemen, H.M.(1);Visschedijk, M.C.(1);Festen, E.A.M.(1);Weersma, R.K.(1);Karsdal, M.A.(2);Faber, K.N.(1);Mortensen, J.H.(2);Dijkstra, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P124 Clock gene expression levels can differentially distinguish between ulcerative colitis and Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Weintraub1, S. Cohen1, N. Chapnik2, A. Yerushalmy-Feler1, A. Ben-Tov1, I. Dotan3, R. Tauman4, O. Froy2

Created: Thursday, 30 January 2020, 10:12 AM
P124: An investigation of taste preference to oral nutritional supplement drinks (ONS) in adolescent and adult Crohn’s disease (CD) and attitudes towards their long-term use
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Keetarut1*, N. Richards2, N. Davies3

Created: Thursday, 21 February 2019, 9:14 AM
P124: Disagreement among gastroenterologists in the endoscopic evaluation using the Mayo endoscopic score and the Rutgeerts postoperative score
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Raimundo Fernandes S.*1, Pinto J.2, Marques da Costa P.1, Correia L.1 Grupo de Estudos de Doença Inflamatόria Intestinal

Created: Wednesday, 20 February 2019, 10:36 AM
P124: Gastroenteropancreatic Neuroendocrine Neoplasms in patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series
Year: 2021
Source: ECCO'21 Virtual
Authors: Festa, S.(1);Zerboni, G.(2);Derikx, L.(3);Ribaldone, D.G.(4);Dragoni, G.(5);Buskens, C.J.(6);Nieveen van Dijkum, E.(6);Pugliese, D.(7);Panzuto, F.(8);Krela-Kaźmierczak, I.(9);Reiss, H.(10);Shitrit, A.B.G.(11);Chaparro, M.(12);Gisbert, J.P.(12);Kopylov, U.(13);Teich, N.(14);Vainer, E.(15);Nagtegaal, I.(16);Hoentjen, F.(3);Garcia, M.J.(17);Filip, R.(18);Foteinogiannopoulou, K.(19);Koutroubakis, I.(19);Argollo, M.(20);van Wanrooij, R.(21);Laja, H.(22);Truyens, M.(23);Lobaton Ortega, T.(23);Molnar, T.(24);Savarino, E.(25);Aratari, A.(1);Papi, C.(1);Goren, I.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P124: Latent and active tuberculosis in patients with inflammatory bowel disease under anti-TNF—data from a centre with high incidence of tuberculosis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Sousa*1, I. Ladeira1, C. Fernandes1, A. Ponte1, A. Rodrigues1, A. P. Silva1, J. Rodrigues1, J. Silva1, C. Gomes1, J. Carvalho1

Created: Friday, 22 February 2019, 9:41 AM
P124: Risk of surgery in inflammatory bowel disease: A systematic review and meta-analysis of sex-based differences
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rasmussen, N.F.(1)*;Gregersen , L.H.K.(1);Hikmat, Z.(2);Moos, C.M.(3);Green, A.(4);Andersen, V.(1);Madsen, G.I.(5);Jess, T.(6);Kjeldsen, L.J.(7);
Created: Friday, 14 July 2023, 10:48 AM